Combined increased and decreased skeletal uptake of F-18 FDG

Clinical Nuclear Medicine

Volumn 31, Issue 9, 2006, Pages 520-522

  Goshen, Elinor ^a   Davidson, Tima ^a   Yeshurun, Moshe ^b   Zwas, S Tzila ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Bone marrow; Lymphoma; PET CT

Indexed keywords

ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; IFOSFAMIDE; MITOXANTRONE;

ADULT; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; B CELL LYMPHOMA; BONE MARROW BIOPSY; BONE MARROW METASTASIS; BONE METASTASIS; CANCER REGRESSION; CANCER RELAPSE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DRUG MEGADOSE; DRUG UPTAKE; FOLLOW UP; HUMAN; HYPERMETABOLISM; LIVER METASTASIS; MALE; PANCYTOPENIA; POSITRON EMISSION TOMOGRAPHY; SPLEEN CANCER; SYMPTOM;

BONE AND BONES; BONE MARROW; BONE NEOPLASMS; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGING, THREE-DIMENSIONAL; LYMPHOMA; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECURRENCE; THORACIC VERTEBRAE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33747599871     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rlu.0000233080.16944.a4     Document Type: Article

References (19)

1. Carr R, Barrington SF, Madan B, et al. Detection of lymphoma in bone marrow by whole-body positron emission tomography. Blood. 1998;91:3340-3346.
2. Naeim F, ed. Pathology of Bone Marrow, 2nd ed. Baltimore: Williams & Wilkins; 1998:90-115.
3. McCarthy DM. Annotation. Fibrosis of the bone marrow: content and causes. Br J Haematol. 1985;59:1-7.
4. Falk S, Seipelt G, Ganser A, et al. Bone marrow findings after treatment with recombinant human interleukin-3. Am J Clin Pathol. 1991;95:355-362.
5. Sopov V, Liberson A, Gorenberg M, et al. Cold vertebrae on bone scintigraphy. Semin Nucl Med. 2001;31:82-83.
6. Shih WJ. Incidental detection of diminished bone marrow metabolic activity with FDG PET. Radiographics. 2001;21:519.
7. Meyer MA, Nathan CA. Reduced F-18 fluorodeoxyglucose uptake within marrow after external beam radiation. Clin Nucl Med. 2000;25:279-280.
8. Bybel B, Raja S. Vertebral hemangiomas on FDG PET scan. Clin Nucl Med. 2003;28:522-523.
9. Hamada K, Myoui A, Ueda T, et al. FDG-PET imaging for chronic expanding hematoma in pelvis with massive bone destruction. Skeletal Radiol. 2005;15 (e-pub).
10. Takalkar A, Yu JQ, Kumar R, et al. Diffuse bone marrow accumulation of FDG in a patient with chronic myeloid leukemia mimics hematopoietic cytokine-mediated FDG uptake on positron emission tomography. Clin Nucl Med. 2004;29:637-639.
11. Endo T, Sato N, Koizumi K, et al. Localized relapse in bone marrow of extremities after allogeneic stem cell transplantation for acute lymphoblastic leukemia. Am J Hematol. 2004;76:279-282.
12. Kuenzle K, Taverna C, Steinert HC. Detection of extramedullary infiltrates in acute myelogenous leukemia with whole-body positron emission tomography and 2-deoxy-2-[18F]-fluoro-D-glucose. Mol Imaging Biol. 2002;4:179-183.
13. Pakos EE, Fotopoulos AD, Ioannidis JP. 18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: a meta-analysis. J Nucl Med. 2005;46:958-963.
14. Blum R, Seymour JF, Hicks RJ. Role of 18FDG-positron emission tomography scanning in the management of histiocytosis. Leuk Lymphoma. 2002;43:2155-2157.
15. Bredella MA, Steinbach L, Caputo G, et al. Value of FDG PET in the assessment of patients with multiple myeloma. AJR Am J Roentgenol. 2005;184:1199-1204.
16. Hollinger EF, Alibazoglu H, Ali A, et al. Hematopoietic cytokinemediated FDG uptake simulates the appearance of diffuse metastatic disease on whole-body PET imaging. Clin Nucl Med. 1998;23:93-98.
17. Mayer D, Bednarczyk EM. Interaction of colony-stimulating factors and fluorodeoxyglucose F(18) positron emission tomography. Ann Pharmacother. 2002;36:1796-1799.
18. Blodgett TM, Ames JT, Torok FS, et al. Diffuse bone marrow uptake on whole-body F-18 fluorodeoxyglucose positron emission tomography in a patient taking recombinant erythropoietin. Clin Nucl Med. 2004;29:161-163.
19. Elstrom RL, Tsai DE, Vergilio JA, et al. Enhanced marrow [18F]fluorodeoxyglucose uptake related to myeloid hyperplasia in Hodgkin's lymphoma can simulate lymphoma involvement in marrow. Clin Lymphoma. 2004;5:62-64.